can tirzepatide cause death Clinical Outcomes of or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes Mounjaro, Zepbound Lowers Risk of

However, development of GIPR- and GCGR-based therapeutics has encountered drawbacks due to the complexity of physiology associated with GIP and GCG 4,5,6

Taking these medicines at the same time does not directly cause a conflict between the drugs

Here's what I, as a physician, see in the current scientific landscape

TL;DR: Tirzepatide is a 39-amino-acid dual GIP/GLP-1 receptor agonist (MW ~4813.45 Da) with a C20 fatty diacid moiety attached via a linker at Lys

These less crowded indications may offer high risk, high reward pathways for manufacturers who are looking to enter the GLP-1 arena without needing to fight for space in the competitive diabetes or obesity markets